Growth Hormone Deficiency in Children Recruiting Phase 2 Trials for Somapacitan (DB15093)

IndicationStatusPhase
DBCOND0034025 (Growth Hormone Deficiency in Children)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02616562Investigating Efficacy and Safety of Once-weekly NNC0195-0092 (Somapacitan) Treatment Compared to Daily Growth Hormone Treatment (Norditropin® FlexPro®) in Growth Hormone Treatment naïve Pre-pubertal Children With Growth Hormone DeficiencyTreatment